INTERNATIONAL PATENT: KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. FILES APPLICATION FOR "COMBINATIONS OF HETEROCYCLIC DNA-PK INHIBITORS AND ANTIBODY-DRUG CONJUGATES (ADC) FOR USE IN THE TREATMENT OF CANCER"

GENEVA, Nov. 24 -- KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD. (4th Floor, Building 2, No. 319, Tsingtao Brewery Avenue,Wenjiang DistrictChendu City, Sichuan) filed a patent application (PCT/IB2025/055140) for "COMBINATIONS OF HETEROCYCLIC DNA-PK INHIBITORS AND ANTIBODY-DRUG CONJUGATES (ADC) FOR USE IN THE TREATMENT OF CANCER" on May 16, 2025. With publication no. WO/2025/238615, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WEI, Yonggang (c/o KANGBAIDA (SICHUAN) BIOTECHNOLOGY CO., LTD.4th Floor, Building 2, No. 319, Ts...